Jemperli 00173-0898
Generic: Dostarlimab
Product NDC
00173-0898- Manufacturer
- Glaxosmithkline Llc
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- April 22, 2021
- Listing Expires
- December 31, 2027
- Application
- BLA761174
Need to source Jemperli? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Dostarlimab | 50 mg/mL |
Drug Class
Programmed Death Receptor-1 Blocking Antibody [EPC]Programmed Death Receptor-1 Blocking Antibody [EPC]Programmed Death Receptor-1-directed Antibody Interactions [MoA]
Packaging Options(1)
1 VIAL in 1 CARTON (0173-0898-03) / 10 mL in 1 VIAL